Shares of Acadia Healthcare Co ACHC fell 0.29% in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share fell 11.48% year over year to $0.54, which beat the estimate of $0.40.
Revenue of $750,311,000 decreased by 4.95% year over year, which missed the estimate of $762,490,000.
Guidance
Earnings guidance hasn't been issued by the company for now.
Acadia Healthcare Co hasn't issued any revenue guidance for the time being.
Conference Call Details
Date: Aug 04, 2020
Time: 09:00 AM
ET Webcast URL: https://edge.media-server.com/mmc/p/vqirz5qb
Price Action
Company's 52-week high was at $35.30
Company's 52-week low was at $11.09
Price action over last quarter: Up 15.55%
Company Profile
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities in the United States, United Kingdom, and Puerto Rico. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The U.S. facilities receive the largest proportion of payments from Medicaid, with the second largest proportion from commercial payors. In the United Kingdom, the majority of Acadia's revenue comes from its healthcare facilities, and virtually all of the payment received is from the National Health Service.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.